Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025 Mont-Saint-Guibert, Belgium – Tuesday July 29, 2025, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the Company will release financial results for

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025 Mont-Saint-Guibert, Belgium – Tuesday July 29, 2025, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the Company will release financial results for

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025 Mont-Saint-Guibert, Belgium – Tuesday July 29, 2025, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the Company will release financial results for

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025 Mont-Saint-Guibert, Belgium – Tuesday July 29, 2025, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the Company will release financial results for

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025 Mont-Saint-Guibert, Belgium – Tuesday July 29, 2025, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the Company will release financial results for

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025 Mont-Saint-Guibert, Belgium – Tuesday July 29, 2025, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the Company will release financial results for

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025 Mont-Saint-Guibert, Belgium – Tuesday July 29, 2025, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the Company will release financial results for

SAN FRANCISCO, July 29, 2025 (GLOBE NEWSWIRE) — Meltwater, a global leader in media, social, and consumer intelligence, today announces the launch of GenAI Lens, an industry-first, groundbreaking tool that gives companies unprecedented visibility into how their brand, competitors and industry are discussed across all major AI Assistants and LLMs (Large Language

SAN FRANCISCO, July 29, 2025 (GLOBE NEWSWIRE) — Meltwater, a global leader in media, social, and consumer intelligence, today announces the launch of GenAI Lens, an industry-first, groundbreaking tool that gives companies unprecedented visibility into how their brand, competitors and industry are discussed across all major AI Assistants and LLMs (Large Language

SAN FRANCISCO, July 29, 2025 (GLOBE NEWSWIRE) — Meltwater, a global leader in media, social, and consumer intelligence, today announces the launch of GenAI Lens, an industry-first, groundbreaking tool that gives companies unprecedented visibility into how their brand, competitors and industry are discussed across all major AI Assistants and LLMs (Large Language

SAN FRANCISCO, July 29, 2025 (GLOBE NEWSWIRE) — Meltwater, a global leader in media, social, and consumer intelligence, today announces the launch of GenAI Lens, an industry-first, groundbreaking tool that gives companies unprecedented visibility into how their brand, competitors and industry are discussed across all major AI Assistants and LLMs (Large Language

SAN FRANCISCO, July 29, 2025 (GLOBE NEWSWIRE) — Meltwater, a global leader in media, social, and consumer intelligence, today announces the launch of GenAI Lens, an industry-first, groundbreaking tool that gives companies unprecedented visibility into how their brand, competitors and industry are discussed across all major AI Assistants and LLMs (Large Language